Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.2 EUR
−272.92 M EUR
1.13 B EUR
60.33 M
About ARGENX SE
Sector
CEO
Tim van Hauwermeiren
Headquarters
Amsterdam
Website
Founded
2008
ISIN
NL0010832176
FIGI
BBG006MF2DW2
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ARGX is featured.
Frequently Asked Questions
The current price of ARGX is 539.8 EUR — it has decreased by −5.00% in the past 24 hours. Watch ARGENX SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange ARGENX SE stocks are traded under the ticker ARGX.
ARGX stock has fallen by −1.71% compared to the previous week, the month change is a 8.52% rise, over the last year ARGENX SE has showed a 19.66% increase.
We've gathered analysts' opinions on ARGENX SE future price: according to them, ARGX price has a max estimate of 664.12 EUR and a min estimate of 525.00 EUR. Watch ARGX chart and read a more detailed ARGENX SE stock forecast: see what analysts think of ARGENX SE and suggest that you do with its stocks.
ARGX reached its all-time high on Nov 14, 2024 with the price of 575.8 EUR, and its all-time low was 6.2 EUR and was reached on Oct 16, 2014. View more price dynamics on ARGX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ARGX stock is 6.25% volatile and has beta coefficient of 1.18. Track ARGENX SE stock price on the chart and check out the list of the most volatile stocks — is ARGENX SE there?
Today ARGENX SE has the market capitalization of 32.59 B, it has increased by 0.90% over the last week.
Yes, you can track ARGENX SE financials in yearly and quarterly reports right on TradingView.
ARGENX SE is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ARGX net income for the last half-year is −30.10 M EUR, while the previous report showed −158.85 M EUR of net income which accounts for 81.05% change. Track more ARGENX SE financial stats to get the full picture.
No, ARGX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 17, 2024, the company has 1.15 K employees. See our rating of the largest employees — is ARGENX SE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARGENX SE EBITDA is −263.27 M EUR, and current EBITDA margin is −27.70%. See more stats in ARGENX SE financial statements.
Like other stocks, ARGX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARGENX SE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARGENX SE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARGENX SE stock shows the buy signal. See more of ARGENX SE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.